Literature DB >> 35977242

US Hospital Characteristics Associated With Price Transparency Regulation Compliance.

Yunan Ji1, Edward Kong2,3.   

Abstract

This cross-sectional study examines associations between characteristics of US hospitals and their compliance with Centers for Medicare & Medicaid Services regulations for transparency of insurance-negotiated prices. Copyright 2022 Ji Y et al. JAMA Health Forum.

Entities:  

Mesh:

Year:  2022        PMID: 35977242      PMCID: PMC9233236          DOI: 10.1001/jamahealthforum.2022.1702

Source DB:  PubMed          Journal:  JAMA Health Forum        ISSN: 2689-0186


Introduction

As of January 1, 2021, the Centers for Medicare & Medicaid Services (CMS) required all US acute care hospitals to release the prices they negotiate with insurance plans to make price comparison across hospitals easier for consumers.[1] We report data on compliance with this requirement for all 4484 acute care hospitals in the US as of December 2021 and explore the association between hospital characteristics and compliance.

Methods

In this cross-sectional study, we included all nonexempt acute care hospitals in the 2017 American Hospital Association (AHA) survey. We classified a hospital as compliant if it publicly posted any private payer–specific negotiated prices at the service code level. We manually collected compliance data from hospital websites and verified whether payer-specific prices were reported. We concluded our first round of data collection in July 2021 and rechecked all noncompliant hospitals between December 5 and 27, 2021, establishing a final compliance rate for 2021. We obtained hospital-level characteristics from the AHA, the CMS Provider of Services File, and the Dartmouth Atlas of Health Care. The Harvard University institutional review board determined this study was not human participants research, exempted it from approval, and waived informed consent. We followed the STROBE reporting guideline. Our unit of observation was a hospital system, defined as 1 or more hospitals in the same integrated health system and hospital referral region (HRR).[2] For each HRR, we used the share of inpatient beds in each hospital system to construct the Herfindahl-Hirschman Index (HHI). Markets with an HHI of 2500 or greater are considered highly concentrated (ie, less competitive). We used bivariate linear regressions to estimate associations between compliance and hospital system characteristics and report results from multivariate regressions. We conducted statistical tests using robust SEs, with significance defined as 2-sided P < .05. Data were analyzed using Stata, version 17 (StataCorp LLC).

Results

The final sample included 2892 hospital systems representing 4484 hospitals in 306 HRRs. The Table shows descriptive statistics at the hospital system level for 2892 hospital systems; mean (SD) compliance was 68% (46%). We found a negative association between compliance and market competitiveness; compliance was higher in less competitive HRRs (scaled effect size, 0.07; 95% CI, 0.03-0.10) and for hospital systems with greater market shares (scaled effect size, 0.08; 95% CI, 0.05-0.11) (Figure). Both associations remained significant when controlling for number of beds. Multihospital systems (effect size, 0.13; 95% CI, 0.09-0.16), for-profit hospitals (effect size, 0.05; 95% CI, 0.01-0.10), and teaching hospitals (effect size, 0.11; 95% CI, 0.03-0.20) had higher compliance. Government hospitals had lower compliance (effect size, −0.06; 95% CI, −0.10 to −0.02), but the association did not remain after controlling for integration into multihospital systems. Hospital systems with more beds had higher compliance (scaled effect size, 0.04; 95% CI, 0.02-0.07), whereas critical access hospitals (effect size, −0.03; 95% CI, −0.07 to 0.01) and those lacking intensive care units (effect size, −0.13; 95% CI, −0.16 to −0.09) had lower compliance.
Table.

Characteristics of 2892 Hospital Systems

CharacteristicMean (SD)Median (IQR)
Compliancea,b0.68 (0.46)1 (0-1)
Market competition
Market concentration, HHI2328 (1348)1955 (1416-3016)
Market share, percentage points10.6 (15.4)3.8 (1.2-12.7)
Ownershipb
Multihospital system0.44 (0.50)0 (0-1)
Private
For-profit0.18 (0.37)0 (0-0)
Nonprofit0.54 (0.49)1 (0-1)
Government0.28 (0.44)0 (0-1)
Size and resources
Beds, No.254 (390)101 (25-302)
Teaching hospitalb0.04 (0.18)0 (0-0)
Critical access hospitalb0.33 (0.45)0 (0-1)
No ICUb0.33 (0.45)0 (0-1)

Abbreviations: HHI, Herfindahl-Hirschman Index; ICU, intensive care unit.

For systems in which some hospitals were compliant and others were noncompliant, the mean compliance rate was assigned. This only applied to 72 (2.5%) of all 2892 systems.

Variables take values of 0 or 1. The mean value represents the proportion of hospital systems in the category among all systems observed.

Figure.

Hospital Factors Associated With Compliance

Coefficient magnitudes for market concentration (Herfindahl-Hirschman Index), market share, and number of beds are reported as a 10th- to 90th-percentile increase (Herfindahl-Hirschman Index, 3021; market share, 31 percentage points; and beds, 655). The 95% CIs were computed using robust SEs. Markers indicate effect sizes, with horizontal lines indicating 95% CIs. ICU, intensive care unit.

Abbreviations: HHI, Herfindahl-Hirschman Index; ICU, intensive care unit. For systems in which some hospitals were compliant and others were noncompliant, the mean compliance rate was assigned. This only applied to 72 (2.5%) of all 2892 systems. Variables take values of 0 or 1. The mean value represents the proportion of hospital systems in the category among all systems observed.

Hospital Factors Associated With Compliance

Coefficient magnitudes for market concentration (Herfindahl-Hirschman Index), market share, and number of beds are reported as a 10th- to 90th-percentile increase (Herfindahl-Hirschman Index, 3021; market share, 31 percentage points; and beds, 655). The 95% CIs were computed using robust SEs. Markers indicate effect sizes, with horizontal lines indicating 95% CIs. ICU, intensive care unit.

Discussion

As of December 2021, 68% of hospitals had released payer-specific negotiated prices, more than 50% higher than rates reported earlier in the year.[3,4,5] The higher compliance rate may be attributable to reporting delays from technical difficulties or pressure from the media and CMS. The findings suggest that competition and hospital resources may have a role in determining compliance. Hospitals in the least competitive markets and those with greater market shares had higher compliance rates, consistent with safeguarding of negotiated prices in the presence of greater competition. A prior study[5] found similar results as of June 1, 2021. In our study, the associations were found through the end of 2021, despite a significant increase in overall compliance. Our results highlight factors associated with hospital compliance with price transparency regulation. A limitation is that we defined compliance based on availability of payer-specific negotiated prices and omitted other CMS requirements such as availability of a shoppable service tool. A more stringent definition would likely lead to lower measured compliance rates.
  4 in total

1.  Hospitals, market share, and consolidation.

Authors:  David M Cutler; Fiona Scott Morton
Journal:  JAMA       Date:  2013-11-13       Impact factor: 56.272

2.  Taking the Pulse of Hospitals' Response to the New Price Transparency Rule.

Authors:  Sayeh Nikpay; Ezra Golberstein; Hannah T Neprash; Caitlin Carroll; Jean M Abraham
Journal:  Med Care Res Rev       Date:  2021-06-19       Impact factor: 3.929

3.  Early Hospital Compliance With Federal Requirements for Price Transparency.

Authors:  Suhas Gondi; Adam L Beckman; Avery A Ofoje; Philip Hinkes; J Michael McWilliams
Journal:  JAMA Intern Med       Date:  2021-10-01       Impact factor: 44.409

4.  Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.

Authors:  John Xuefeng Jiang; Daniel Polsky; Jeff Littlejohn; Yuchen Wang; Hossein Zare; Ge Bai
Journal:  J Gen Intern Med       Date:  2021-12-13       Impact factor: 6.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.